Pharmacologic treatment of acute major depression and dysthymia. American College of Physicians-American Society of Internal Medicine.
about
Interventions for treating depression after strokeInterventions for treating depression after strokeRational treatment choices for non-major depressions in primary care: an evidence-based reviewAssociations of 5HTTLPR polymorphism with major depressive disorder and alcohol dependence: A systematic review and meta-analysis.A practical approach to the treatment of depression in patients with chronic kidney disease and end-stage renal disease.Quality indicators for care of depression in primary care settings: a systematic review.Are anxiety and depression addressed in primary care patients with chronic obstructive pulmonary disease? A chart reviewManagement of depression in elderly stroke patients.Proteinuria is associated with quality of life and depression in adults with primary glomerulopathy and preserved renal functionSerotonin syndrome risks when combining SSRI/SNRI drugs and triptans: is the FDA's alert warranted?Epidemiology, diagnosis, and management of depression in patients with CKD.Validation of depression screening scales in patients with CKDDepression in end-stage renal disease patients treated with hemodialysis: tools, correlates, outcomes, and needs.St John's wort or sertraline? Randomized controlled trial in primary carePrimary care visit length, quality, and satisfaction for standardized patients with depressionAntidepressant medication use in palliative care.Rationale and design of the Chronic Kidney Disease Antidepressant Sertraline Trial (CAST).What Are the Implications of the STAR*D Trial for Primary Care? A Review and SynthesisAntidepressant use and cognitive functioning in older medical patients with major or minor depression: a prospective cohort study with database linkage.Depression in end-stage renal disease hemodialysis patients.Quality indicators for the care of depression in vulnerable elders.Efficacy and feasibility of antidepressant treatment in patients with post-stroke depressionKnowledge About Recommended Treatment and Management of Major Depressive Disorder, Panic Disorder, and Generalized Anxiety Disorder Among Family Physicians.QSAR study on dual 5-HT1A and 5-HT1B antagonists: an insight into the structural requirement for antidepressant activity.Relationships of alcohol use, stress, avoidance coping, and other factors with mental health in a highly educated workforce.Randomized trial of the effect of research design and publication characteristics on physician changeHeadache treatment before and after the consultation of a specialized centre: a pharmacoepidemiology study.A double-blind, randomized, 26-week study comparing the cognitive and psychomotor effects and efficacy of 75 mg (37.5 mg b.i.d.) venlafaxine and 75 mg (25 mg mane, 50 mg nocte) dothiepin in elderly patients with moderate major depression being treatInterventions for management of post-stroke depression: A Bayesian network meta-analysis of 23 randomized controlled trials.Depression and sexual dysfunction in chronic kidney disease: a narrative review of the evidence in areas of significant unmet need.Dietary fats in relation to depressive symptoms by cardiovascular disease risk factors status of elderly people living in Mediterranean islands.Potentially inappropriate management of depressive symptoms among Ontario home care clients.Public awareness about depression: the effectiveness of a patient guideline.Efficacy and tolerability of pharmacotherapy for post-stroke depression: a network meta-analysis.
P2860
Q24240748-08ABD9B6-24FE-46B4-9D5F-C760081ABAA5Q24246641-E1CFB88D-8BDE-46B2-9D68-1EF22D81FA60Q24550595-5EB34165-A835-431F-9FC6-4C6DE1EA2919Q30251779-DDF2A4B1-34DE-434A-8EE8-568B85D215F6Q30408395-5A333882-FE43-4A85-9283-6FAF35E3AC14Q33869020-D18BD1E0-1791-4D23-83C6-81AFC297BE6CQ34084147-615405F8-8E04-4628-8F2F-20527F6BCC72Q34123004-86117EEB-EECA-4D40-9AF9-96F6C38E35F1Q34291259-447FFE49-CF66-4640-BC46-D3D52C362814Q34867700-82DBC91A-F296-4177-B641-83760D3790B4Q35553004-D12588B6-F70C-48A8-8BE7-D91443FDD4ACQ35554566-31BC6D0A-4385-4160-94CD-48EC3291AAD1Q36072516-85A78CE0-1438-494E-82FD-93B8EBECE7A1Q36405837-DE95BD11-4316-4051-90A0-739D1E208361Q36416924-E2BAC68B-89CF-400B-AF8C-67B89A4428C5Q36435443-DB20AE26-308E-4F83-BEA9-5414DCEBE315Q36476538-4703831B-D0C2-41B3-B370-CC7AB741070BQ36538439-75C01932-D05F-4188-A646-43E8F05D4280Q36573742-5905BACF-6CF2-4653-9755-E17BEA8DF073Q36662469-958A0A3F-DF68-4A9B-B6B7-CB252C66AEB0Q36957857-758DF2DD-C4B2-4B5E-8A45-A2C6536D1B1AQ37409568-B0FBA83F-5036-4400-B77F-FD7C3773C1F6Q37490496-E583B487-B69C-439A-8CAC-AA44C9D2595EQ39994945-D1C86D3F-F7C1-4382-BB83-09AD8ED5E206Q40599928-8BA56F68-4D69-4464-84A9-FC16088B8BDFQ42373261-2AF3EC96-1931-4196-BBE5-CB060ABC21BAQ44850904-09DDFDE3-E3E4-4A4D-A903-0FC73267558FQ44983991-F9F8586C-05D7-4D58-A334-15F83D947AE2Q47158437-86F6CD1C-20FC-4227-9EA0-216CBC362FA4Q48224940-4F8BFF7E-8671-41A2-B9E2-9F6CE1CAAE46Q48970780-9211FFDB-7727-46F8-8AAA-A93B0DB3B77EQ51894502-A03C4C2E-8B60-490E-9837-C198ADB193E1Q52088765-D547582C-F2F9-4F9C-8583-992272BC385AQ55116630-1B8B20C4-D3AC-4EF6-ACF4-9279D5DCF0A8
P2860
Pharmacologic treatment of acute major depression and dysthymia. American College of Physicians-American Society of Internal Medicine.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Pharmacologic treatment of acu ...... Society of Internal Medicine.
@en
Pharmacologic treatment of acu ...... Society of Internal Medicine.
@nl
type
label
Pharmacologic treatment of acu ...... Society of Internal Medicine.
@en
Pharmacologic treatment of acu ...... Society of Internal Medicine.
@nl
prefLabel
Pharmacologic treatment of acu ...... Society of Internal Medicine.
@en
Pharmacologic treatment of acu ...... Society of Internal Medicine.
@nl
P2093
P1476
Pharmacologic treatment of acu ...... Society of Internal Medicine.
@en
P2093
Mottur-Pilson C
P304
P356
10.7326/0003-4819-132-9-200005020-00010
P407
P577
2000-05-01T00:00:00Z